Formal Name of the Test:
Herpes Simplex Virus 1 and 2 (IgG), Type-Specific Antibodies
Other Names Used:
Herpes-1 and 2; HSV Types 1- and 2-Specific Antibodies, IgG; HSV-1 and 2; Herpes Simplex Virus 1/2 (IgG), Type-Specific Antibodies
The Herpes Simplex Virus (HSV) causes a number of clinically significant human viral illnesses, ranging in severity from mild to fatal. Genital tract infections, newborn herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis are some of the clinical symptoms. There are two HSV serotypes that are antigenically related. HSV Type 2 infections are more common in the genital tract and in newborns, whereas HSV Type 1 infections are more common in non-genital regions. In most cases, a specific type isn’t required for diagnosis or therapy. Using the type-specific assay, the average duration of seroconversion is 25 days. This assay’s performance in a pediatric population, for neonatal screening, or for testing immunocompromised patients has not been proven.
There is no need for any prior preparation.
Test Performed at:
Quest Diagnostics, Test Code 6447
Click here to go to Quest Diagnostics page for this test